Image

Global Solid Organ Transplantation Market – Industry Trends and Forecast to 2029

Pharmaceutical

Image

Global Solid Organ Transplantation Market – Industry Trends and Forecast to 2029

  • Pharmaceutical
  • Upcoming Report
  • Oct 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Solid Organ Transplantation Market, By Organ (Kidney, Liver, Pancreas, Heart, Lung, Small Bowel, Kidney/Pancreas, Others), Product (Tissue Products, Immunosuppressive Drugs, Preservation Solution), Treatment (Immunosuppressive, Monoclonal Antibodies, Others), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029.

Solid Organ Transplantation Market

Solid Organ Transplantation Market Analysis and Size

The global solid organ transplantation market is expected to witness significant growth during the forecast period. Increasing demand for novel tissue transplantation products and organ transplantation for the treatment of organ failure is a foremost factor leading to the market growth. Unhealthy dietary habits, lack of exercise, alcohol consumption, and drug abuse are some important causes of organ failure. It has been witnessed that tissue products were the highest revenue-generating segment in 2021 having a market share of 57.8%. COVID-19 also had a major impact on the market growth.

Data Bridge Market Research analyses a growth rate in the global solid organ transplantation market  in the forecast period 2022-2029. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Market Definition

Solid organ transplantation works like an advantage for patients suffering from end-stage kidney, pancreas, small intestine, heart, liver, and lung diseases. Although, it is not a process that improves survival, certain quality-of-life improvements are realized with vascular composite allograft and uterus transplantation. It is of great importance to the healthcare sector and thus is expected to rise high in the forecast period.

Solid Organ Transplantation Market Scope and Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Organ (Kidney, Liver, Pancreas, Heart, Lung, Small Bowel, Kidney/Pancreas, Others), Product (Tissue Products, Immunosuppressive Drugs, Preservation Solution), Treatment (Immunosuppressive, Monoclonal Antibodies, Others), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Teva Pharmaceutical Industries Ltd (Israel), Mylan N.V (U.S.), Johnsons & Johnsons Services Inc (U.S.), F. Hoffman-La Roche Ltd. (Switzerland), Lilly (U.S.), Merck & Co., Inc. (U.S.), Aurobindo Pharma (India), Bristol-Myers Squibb Company (U.S.), GSK plc (U.K.), Ascendis Pharma A/S (Denmark), LEO Pharma A/S (Denmark), Genentech, Inc (U.S.), Celltrion Inc (South Korea)

Market Opportunities

  • Increasing Sales of Immunosuppressive Drugs
  • Higher Mergers and Acquisitions

Global Solid Organ Transplantation Market Dynamics

Drivers

  • Growing Demand for Organ Transplant

The global rise in the organ transplant demand can be attributed to an increase in the occurrence of acute diseases, which in turn leads to an increase in the number of organ failures. For instance, diabetes and high blood pressure are considered to be the most common causes of end-stage renal disease, wherein kidney transplants or dialysis are the only treatment options to keep a patient alive. As per the records of the U.S. Department of Health & Human Services, about 122,913 patients in the U.S. were waiting to receive organs for transplant in 2019. Thus, the demand for advanced transplantation products for the treatment of organ failure is high.This boosts the market growth.

  • Technological Advancements

Several technological advancemnets in this sector are expected to boost the growth of the market. For instance, in September 2015, Arthrex Inc. launched ArthroFlex Acellular Dermal Matrix, a new orthobiologic product proposed for use in capsular reconstruction. This product allows preservation of its growth factors and native collagen scaffold and elastin and permits transplant to be successfully incorporated into the recipient. All these factors boost the market growth.

Opportunities

  • Higher Mergers and Acquisitions

Several manufacturers are aiming on new product development, mergers & acquisition, and collaborations to enlarge their current product portfolio and maintain their persistent position in the market. For instance, in September 2016, Stryker Corporation announced the acquisition of Instratek. It is a top manufacturer of minimally invasive soft tissue recession instruments for ankle, foot, and upper extremity procedures.

  • Increasing Sales of Immunosuppressive Drugs

Tissue products for transplantation accounted for the largest share in 2021, and this category is projected to maintain its position in the upcoming future due to the increasing use of orthobiologics in orthopedic procedures for normal functioning restoration, tissue healing, and pain minimization, combined with the increasing elderly population across the globe. Moreover, startup companies in this field are receiving investments to expand their business. Thus, this factor is creating much opportunities for the market growth.

Restraints/Challenges

  • High Cost

The huge association with organ transplantation and many other immunosuppressive drugs restrain the market growth.

  • Unavailability of Treatment

Not all the treatments are available in all the countries which restrict the market growth. There are several underdeveloped countries wherein the modified treatments are not available.  Thus, it restricts the growth of the market.

This global solid organ transplantation market  report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global solid organ transplantation market  contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Solid Organ Transplantation Market       

There has been a significant proportion of coronavirus patients who were hospitalized in medical centers, governing bodies were bound to restrict to these patients. The pandemic also caused a drip in organ transplant surgery enrolment globally.

The reduction in the number of transplantation and organ donation procedures is mostly because of factors such as engaged surgeons, unavailability of resources, lockdown, and travel restrictions. Patients having positive reports for COVID-19 were restricted from donating organs because of the possibility of infection. Additionally, another major concern prompting transplantation operations was the possibility of immunosuppressant drug interactions with COVID-19 therapy agents, which had led to a substantial number of organ failures from graft donors.  

Recent Development:

  • In November 2020, Lupin launched a generic immunosuppressant drug, Tacrolimus in the U.S. market which is indicated for prophylaxis of organ rejection in the allogeneic liver, kidney, and heart transplant.

Global Solid Organ Transplantation Market Scope

The global solid organ transplantation market  is segmented on the basis of organ, product, treatment, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Organ

  • Kidney
  • Liver
  • Pancreas
  • Heart
  • Lung
  • Small Bowel
  •  Kidney/Pancreas
  •  Others

Product

  • Tissue Products
  • Immunosuppressive Drugs
  • Preservation Solution

Treatment

  • Immunosuppressive
  • Monoclonal Antibodies
  • Others

End-Users

  • Hospitals
  • Homecare
  • Speciality Centres
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Solid Organ Transplantation Market Regional Analysis/Insights

The global solid organ transplantation market  is analysed and market size insights and trends are provided by organ, product, treatment, distribution channel and end-user as referenced above.

The major countries covered in the global solid organ transplantation market  report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is expected to have the highest market growth due to the presence of key manufacture of the product and increased healthcare and R & D expenditure.

Asia-Pacific dominates the market due to increased prevalence of organ failure, and presence of generic drugs manufacturers.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Solid Organ Transplantation Market Share Analysis

The global solid organ transplantation market  competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global solid organ transplantation market.

Key players operating in the global solid organ transplantation market  include:

  • Teva Pharmaceutical Industries Ltd (Israel)
  • Mylan N.V (U.S.)
  • Johnsons & Johnsons Services Inc (U.S.)
  • F. Hoffman-La Roche Ltd. (Switzerland)
  • Lilly (U.S.)
  • Merck & Co., Inc. (U.S.)
  • Aurobindo Pharma (India)
  • Bristol-Myers Squibb Company (U.S.)
  • GSK plc (U.K.)
  • Ascendis Pharma A/S (Denmark)
  • LEO Pharma A/S (Denmark)
  • Genentech, Inc (U.S.)
  • Celltrion Inc (South Korea)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

Factors such as technological advancements and growing demand for organ transplant are acting as the major drivers for the global solid organ transplantation market.
Teva Pharmaceutical Industries Ltd (Israel), Mylan N.V (U.S.), Johnsons & Johnsons Services Inc (U.S.), F. Hoffman-La Roche Ltd. (Switzerland), Lilly (U.S.), Merck & Co., Inc. (U.S.), Aurobindo Pharma (India), Bristol-Myers Squibb Company (U.S.), GSK plc (UK), Ascendis Pharma A/S (Denmark), LEO Pharma A/S (Denmark), Genentech, Inc (U.S.), Celltrion Inc (South Korea).
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials